Awards

CooperVision’s MiSight^® 1 day soft contact lens received a Special Mention in the Excellence in Business to Consumer, Medical & Health category at the 2022 German Innovation Award ceremony. This recognition is given to products that add meaningful advancements to earlier solutions across different industries and sectors. MiSight^® 1 day lenses have a proven ability to slow the progression of myopia in children aged 8-12 at the initiation of treatment. ^†1

^† Compared to a single vision 1-day lens over a 3 year period.

CooperVision’s MiSight^® 1 day soft contact lens won the 2021 Health Care Asia (HCA) Med Tech Award in the “Singapore Patient Advocacy Program of the Year” category. This award is presented for medical technologies that are seen to be the future of the healthcare in the Asia Pacific region. MiSight^® 1 day, which helps slow the progression of myopia in children aged 8-12 at the initiation of treatment, ^†1 is approved for use in several major Asian Pacific countries, an important step as myopia’s prevalence in the region has reached epidemic levels.

A trio of myopia management visionaries has been honored with the prestigious British Contact Lens Association (BCLA) Industry Award for their work developing, researching and commercializing the innovative CooperVision^® MiSight^® 1 day contact lens. John Phillips, Stuart Cockerill and Paul Chamberlain were recognized on Saturday evening at the BCLA Clinical Conference & Exhibition closing gala dinner, selected from a field of finalists who have all made immeasurable contributions to the field.

CooperVision's Pulse Magazine is a quarterly publication dedicated to helping ECP’s with their practice management and marketing. It recently won a Hermes Creative Award, an annual international competition for creative professionals.